Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Administration of Low Dose Adrenaline During Surgery on Bleeding During Hip Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years.~* Scheduled for primary unilateral hip arthroplasty~* Able to give consent~Exclusion Criteria:~* Allergy towards adrenaline~* Current treatment with: ADP receptor inhibitors or Vitamin K antagonists (within 5 days), Factor Xa inhibitors or Thrombin inhibitors (within 1 day), heparin (excluding low molecular weight heparin for perioperative thromboprophylaxis).~* Current treatment with tricyclic antidepressants~* Use of MAO inhibitors (within previous 14 days) or COMT inhibitors (within 2 days).~* Acute coronary syndrome / myocardial infarction within the previous 6 months.~* not willing to accept blood transfusion~* Participation in other clinical trial within previous 30 days~* Women of childbearing age (without menopause for at least 12 months)~* Glaucoma~* Pheochromocytoma~* Low serum K+ (\< 3.0 mmol/L)~* Thyrotoxicosis~* Digoxin intoxication~* Alcohol og drug abuse (investigators judgement)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Adrenaline (Type: EXPERIMENTAL): Intraoperative low-dose adrenaline infusion
- Placebo (Type: PLACEBO_COMPARATOR): Placebo: Isotonic Saline

Based on this trial design, predict the completion outcome and termination type (if applicable).